Sygnature Discovery logo

Sygnature Discovery

#BeyondBoundaries

626 employees · est. 2004 · Nottingham, United Kingdom

VS
Ventus Therapeutics logo

Ventus Therapeutics

Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and Montreal, QC.

55 employees · est. 2019 · Waltham, United States

Sygnature Discovery is the older company (2004 vs 2019); Sygnature Discovery is the larger of the two.

Side-by-Side Comparison

Sygnature Discovery Ventus Therapeutics
Founded
2004 older 2019
Headquarters
Nottingham, United Kingdom Waltham, United States
Employees
626 larger 55
Industry
Biotechnology Biotechnology, Health Care, Health and Wellness
Funding Stage
Secondary Market Grant
Total Funding
Not tracked yet $370.15M
Funding Rounds
2 5
Services
Integrated Drug Discovery, Computer Aided Drug Design, Protein and Structure Analysis, Bioscience Solutions, Pharmacokinetics Assessment, Therapeutic Development, Chemical and Medicinal Chemistry Not tracked yet
Target Customers
Biotech Companies, Pharmaceutical Companies, Research Teams in Drug Development, Startups in Drug Discovery Not tracked yet
Taxonomy
Drug Discovery CRO, Integrated Drug Discovery, Oncology, Inflammation And Immunology, Neuroscience, Metabolic Diseases, Respiratory Diseases, Infectious Diseases, Fibrotic Diseases, Medicinal Chemistry, In Vitro Bioscience, Computational Chemistry, DMPK, Protein Crystallography, Drug Formulation Structure-based Drug Discovery, Biopharmaceutical, Computational Chemistry, Medicinal Chemistry, Autoimmune Diseases, Inflammatory Diseases, Neurological Disorders, Cancer Treatment, Drug Development Process, Protein Modeling, Chemical Matter Library, Pipeline Development, Structural Biology, Business Development, Data-driven Drug Discovery
Website
sygnaturediscovery.com ventustx.com
Sygnature Discovery logo

About Sygnature Discovery

Sygnature Discovery, a prominent name in the Biotechnology sector, is a global drug discovery CRO with a track record of creating exceptional scientific outcomes. Founded in 2004 in the United Kingdom, the company employs over 700 scientists from 50+ countries, reflecting a diverse and highly skille...

Ventus Therapeutics logo

About Ventus Therapeutics

Ventus Therapeutics is undeniably a frontrunner in the biotechnology, health care, and pharmaceutical industries. Established in 2019 and headquartered in the United States, with a secondary location in Montreal, QC, the company has been pioneering a distinctive approach to structure-based drug disc...

We will tell you when either one moves

BounceWatch watches Sygnature Discovery and Ventus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Sygnature Discovery and Ventus Therapeutics — by email.

Frequently Asked Questions

Sygnature Discovery — #BeyondBoundaries. Ventus Therapeutics — Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and Montreal, QC.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Sygnature Discovery has raised undisclosed funding while Ventus Therapeutics has raised $370.15M.
Sygnature Discovery and Ventus Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Sygnature Discovery with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Sygnature Discovery on 15 Jun 2026, and Ventus Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes